Newfound biomarkers may someday help clinicians better detect—and possibly cure—Lyme disea

Newfound biomarkers may someday help clinicians better detect—and possibly cure—Lyme disease. Lyme disease can be easiest to treat in its earliest stages, but current tests often miss infections during that critical window and cannot tell whether bacteria are still present or were cleared years ago.

A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.

Trechos de apoio da pauta: Lyme disease can be easiest to treat in its earliest stages, but current tests often miss infections during that critical window and cannot tell whether bacteria are still present or were cleared years ago. New research led by Tufts University School of Medicine suggests that a group of immune molecules called anti-lipid antibodies may address these shortcomings.

• Ponto de atenção: newfound.
• Ponto de atenção: biomarkers.
• Ponto de atenção: someday.

Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.